Legislation Search

H.R. 4396: Uterine Cancer Study Act of 2025

This bill, known as the Uterine Cancer Study Act of 2025, aims to direct the Secretary of Health and Human Services to conduct a comprehensive study on the relationship between hair straighteners and uterine cancer, with specific attention to the higher incidence of this type of cancer among women of color. The key components of the bill are as follows:

Scope of the Study

The study will focus on several key areas, including:

Reviewing significant findings and recommendations from existing studies related to hair straighteners and uterine cancer.
Considering the impacts on women and individuals at risk of uterine cancer from various racial and ethnic backgrounds.
Disaggregating study results based on whether hair straighteners include dyes, bleaches, highlights, or perms.
Determining if the Food and Drug Administration (FDA) should create additional testing requirements for hair straightening product manufacturers to ensure their safety.

Methodology and Timeline

The Secretary of Health and Human Services is required to provide a detailed methodology for the study to relevant congressional committees within 45 days of the bill's enactment. The actual study must begin within 180 days of the enactment.

Reporting Requirements

Once the study is completed, the Secretary must submit a report detailing the study's findings to both the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate within two years of the bill's enactment.

Definitions

For clarity within the bill:

The term hair straightener refers specifically to chemical hair straighteners.
The term Secretary designates the Secretary of Health and Human Services.